Prostate Cancer

Editor's Choice

Making good decisions requires that physicians have reliable and practical data. Comparative effectiveness reviews and objective findings on different medical interventions and strategies, as provided by the Agency for Healthcare Research and Quality in its Effective Health Care Program, can help physicians make the most informed choices among treatment options.

LATEST ARTICLES

Effective Health Care Clinician Guides

Physician's Focus: Screening for Prostate Specific Antigen

Prostate-specific antigen (PSA) is the serum biomarker most widely used to screen for prostate cancer and monitor patients with disease. Efforts to standardize PSA assays were undertaken a decade ago, but PSA standardization remains controversial. ModernMedicine presents information to help you decide how to best use the PSA marker.

Physician's Focus: Radiation Risk in Urolithiasis

Imaging procedures for diagnosing stone disease have been found to be a major source of ionizing radiation to patient, especially young and middle-aged, and practitioner alike. As a result, the FDA has called for a reduction in radiation exposure. ModernMedicine's articles describe the risks and the potential methods to reduce exposure.

Physician's Focus: Androgen Deprivation Therapy: Risks & Side Effects

With data emerging suggesting side effects from cognitive decline to diabetes and cardiovascular disease, many clinicians are re-evaluating their use of ADT in treating prostate cancer.

Physician's Focus: Radiation Risk in Prostate Cancer

The ECRI Institute has named high radiation doses from computed tomography as number four on its 2010 list of top 10 health technology hazards. This follows on the heels of a key study published in the British Medical Journal in which researchers found an elevated risk for stroke and heart disease was associated with exposure to radiation doses above 0.5 Gy.